검색어: dvylikapirstes zarnos opa (리투아니아어 - 영어)

dvylikapirstes zarnos opa
dean matthews

dvylikapirsts zarnos opa:
4.2 posology and method of administration

dvylikapirsts zarnos opos gydymas:
treatment of duodenal ulcer:

dvylikapirsts zarnos opoms gydyti:
treatment of gastric ulcer:

skrandzio ir dvylikapirsts zarnos op gydymui "
continuous nsaid-treatment "

-dvylikapirsts zarnos ir skrandzio opoms gydyti
-treatment of duodenal and stomach ulcer

gerybinms skrandzio ir dvylikapirsts zarnos opoms gydyti.
continuous nsaid-treatment

gerybins su nspup susijusios skrandzio ir dvylikapirsts zarnos opos:
benign nsaid-associated gastric and duodenal ulcers:

dvylikapirsts zarnos opoms gydyti:30 mg kasdien 2 savaites.
treatment of duodenal ulcer: one 30 mg capsule every day for 2 weeks

· priesuzdegimini vaist sukeltos skrandzio ir dvylikapirsts zarnos opos profilaktika ir
· prophylaxis of gastric and duodenal ulcer associated with the use of anti-inflammatory agents

· endoskopiskai ir radiografiskai patvirtintai skrandzio ir dvylikapirsts zarnos opai gydyti.
4.1 therapeutic indications· treatment of duodenal and gastric ulcer confirmed by endoscopy or radiography.

-dvylikapirsts zarnos ir skrandzio opoms gydyti (diagnozuotoms gastroskopijos metu arba
-to treat ulcers in the duodenum and stomach (diagnosed through gastroscopy or x-ray)

· skrandzio ir dvylikapirsts zarnos op, siejam su nvnu vartojimu, profilaktikai esantiems
· prophylaxis of nsaid-associated gastric ulcers and duodenal ulcers in patients at risk (see section

h. pylori isnaikinimas pasirod ess geriausias dvylikapirsts zarnos op ir daugelio skrandzio op gydymo bdas.
eradication of h. pylori has been shown to be a definitive cure for duodenum ulcer and most gastric ulcers.

dvylikapirsts zarnos ir skrandzio opos gydymas nuolatos nvnu vartojantiems pacientams:30 mg kasdien 4 savaites.
treatment of duodenal or stomach ulcer in patients requiring continued nsaid treatment: one 30 mg capsule every day for 4 weeks.

skrandzio ir dvylikapirsts zarnos opos bei refliuksinis ezofagito diagnoz turi bti patvirtinami endoskopiskai arba kitomis tinkamomis diagnostikos priemonmis.
the diagnosis of gastroduodenal ulcers and reflux oesophagitis should be confirmed by endoscopy or other appropriate diagnostic means.

pateikti duomenys apie palaikomosios priessekrecins terapijos taikym apsaugant nuo dvylikapirsts zarnos opos recidyvo yra ankstesni uz duomenis apie bakterijas naikinanci terapij.
the submitted data on the use of maintenance antisecretory therapy to prevent duodenal ulcer recurrence predates the use of such eradication therapy. s.

dvylikapirsts zarnos opoms gydyti rekomenduojama doz yra 2 kapsuls vien kart per dien (lygu 30 mg lansoprazolio) 2 savaites.
treatment of duodenal ulcers the recommended dose is 2 capsules once daily (equivalent to 30 mg lansoprazole) for 2 weeks.

turimi riboti duomenys ir gerai zinomi klinikiniai faktai apie dvylikapirsts zarnos opas ir ppi klas patvirtina, kad indikacij btina traukti dvylikapirsts zarnos op gydym.
limited data, well known-clinical facts about duodenal ulceration and an class effect of ppis support the inclusion of duodenal ulcers into the indication.

nvnu sukeliam skrandzio op, dvylikapirsts zarnos op ir skrandzio ir dvylikapirsts zarnos erozij gydymas, j simptom mazinimas pacientams, kuriems reikalingas nuolatinis gydymas nvnu
treatment of nsaid-associated gastric ulcers, duodenal ulcers and gastroduodenal erosions, and relief of the associated symptoms, in patients requiring continued nsaid treatment gastric acid is central in the pathogenesis of gastroduodenal ulcers and acid inhibition has been shown to effectively heal nsaid-associated ulcers.